Skip Navigation

European Heart Journal 2003 24(5):442-463; doi:10.1016/S0195-668X(02)00823-0
Copyright © 2003 by the European Society of Cardiology.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (231)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Cleland, J.G.F
Right arrow Articles by Mason, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cleland, J.G.F
Right arrow Articles by Mason, J
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

The EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure in Europe

Part 1: patient characteristics and diagnosis

J.G.F Clelanda,*, K Swedbergb, F Follathc, M Komajdad, A Cohen-Solale, J.C Aguilarf, R Dietzg, A Gavazzih, R Hobbsi, J Korewickij, H.C Madeirak, V.S Moiseyevl, I Predam, W.H van Gilstn, J Widimskyo for the Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology, N Freemantlep, Joanne Eastaughp and J Masonq

a Department of Cardiology, University of Hull, Castle Hill Hospital, Castle Road, Kingston upon Hull HU16 5JQ, UK;b Göteborg, Sweden;c Zurich, Switzerland;d Paris, France;e Clichy, France;f Valencia, Spain;g Berlin, Germany;h Bergamo, Italy;i Birmingham, UK;j Warsaw, Poland;k Lisbon, Portugal;l Moscow, Russia;m Budapest, Hungary;n Groningen, The Netherlands;o Prague, Czech Republic;p Department of Primary Care & General Practice, University of Birmingham, UK;q Newcastle, UK

Received November 8, 2002; accepted November 20, 2002 * Corresponding author. Tel.: +44-1482-624084; fax: +44-1482-624085
E-mail address: j.g.cleland{at}hull.ac.uk

Background The European Society of Cardiology (ESC) has published guidelines for the investigation of patients with suspected heart failure and, if the diagnosis is proven, their subsequent management. Hospitalisation provides a key point of care at which time diagnosis and treatment may be refined to improve outcome for a group of patients with a high morbidity and mortality. However, little international data exists to describe the features and management of such patients. Accordingly, the EuroHeart Failure survey was conducted to ascertain if appropriate tests were being performed with which to confirm or refute a diagnosis of heart failure and how this influenced subsequent management.

Methods The survey screened consecutive deaths and discharges during 2000–2001 predominantly from medical wards over a 6-week period in 115 hospitals from 24 countries belonging to the ESC, to identify patients with known or suspected heart failure.

Results A total of 46,788 deaths and discharges were screened from which 11,327 (24%) patients were enrolled with suspected or confirmed heart failure. Forty-seven percent of those enrolled were women. Fifty-one percent of women and 30% of men were aged >75 years. Eighty-three percent of patients had a diagnosis of heart failure made on or prior to the index admission. Heart failure was the principal reason for admission in 40%. The great majority of patients (>90%) had had an ECG, chest X-ray, haemoglobin and electrolytes measured as recommended in ESC guidelines, but only 66% had ever had an echocardiogram. Left ventricular ejection fraction had been measured in 57% of men and 41% of women, usually by echocardiography (84%) and was <40% in 51% of men but only in 28% of women. Forty-five percent of women and 22% of men were reported to have normal left ventricular systolic function by qualitative echocardiographic assessment. A substantial proportion of patients had alternative explanations for heart failure other than left ventricular systolic or diastolic dysfunction, including valve disease. Within 12 weeks of discharge, 24% of patients had been readmitted. A total of 1408 of 10,434 (13.5%) patients died between admission and 12 weeks follow-up.

Conclusions Known or suspected heart failure comprises a large proportion of admissions to medical wards and such patients are at high risk of early readmission and death. Many of the basic investigations recommended by the ESC were usually carried out, although it is not clear whether this was by design or part of a general routine for all patients being admitted regardless of diagnosis. The investigation most specific for patients with suspected heart failure (echocardiography) was performed less frequently, suggesting that the diagnosis of heart failure is still relatively neglected. Most men but a minority of women who underwent investigation of cardiac function had evidence of moderate or severe left ventricular dysfunction, the main target of current advances in the treatment of heart failure. Considerable diagnostic uncertainty remains for many patients with suspected heart failure, even after echocardiography, which must be resolved in order to target existing and new therapies and services effectively.

Key Words: Heart failure • Survey • Diagnosis • Mortality • Re-admission


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur Heart JHome page
A. Torabi, J. G.F. Cleland, N. K. Khan, P. H. Loh, A. L. Clark, F. Alamgir, J. L. Caplin, A. S. Rigby, and K. Goode
The timing of development and subsequent clinical course of heart failure after a myocardial infarction
Eur. Heart J., April 1, 2008; 29(7): 859 - 870.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. S. Pang, J. G.F. Cleland, J. R. Teerlink, S. P. Collins, C. J. Lindsell, G. Sopko, W. F. Peacock, G. C. Fonarow, A. Z. Aldeen, J. D. Kirk, et al.
A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach
Eur. Heart J., March 2, 2008; 29(6): 816 - 824.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
M J Lenzen, A Rosengren, W J M S. op Reimer, F Follath, E Boersma, M L Simoons, J G F Cleland, and M Komajda
Management of patients with heart failure in clinical practice: differences between men and women
Heart, March 1, 2008; 94(3): e10 - e10.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
F. Zannad, W. G. Stough, B. Pitt, J. G.F. Cleland, K. F. Adams, N. L. Geller, C. Torp-Pedersen, B.-A. Kirwan, and F. Follath
Heart failure as an endpoint in heart failure and non-heart failure cardiovascular clinical trials: the need for a consensus definition
Eur. Heart J., February 1, 2008; 29(3): 413 - 421.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
E D Nicol, B Fittall, M Roughton, J G F Cleland, H Dargie, and M R Cowie
NHS heart failure survey: a survey of acute heart failure admissions in England, Wales and Northern Ireland
Heart, February 1, 2008; 94(2): 172 - 177.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
C. Leclercq
Upgrading from right ventricular pacing to biventricular pacing in pacemaker patients with chronic heart failure
Heart, January 1, 2008; 94(1): 102 - 107.
[Full Text] [PDF]


Home page
Eur Heart JHome page
W. J. Paulus, C. Tschope, J. E. Sanderson, C. Rusconi, F. A. Flachskampf, F. E. Rademakers, P. Marino, O. A. Smiseth, G. De Keulenaer, A. F. Leite-Moreira, et al.
How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology
Eur. Heart J., October 2, 2007; 28(20): 2539 - 2550.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
K. Swedberg
Pure heart rate reduction: further perspectives in heart failure
Eur. Heart J. Suppl., September 1, 2007; 9(suppl_F): F20 - F24.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
T. Breidthardt, M. Christ, M. Matti, D. Schrafl, K. Laule, M. Noveanu, T. Boldanova, T. Klima, W. Hochholzer, A. P Perruchoud, et al.
QRS and QTc interval prolongation in the prediction of long-term mortality of patients with acute destabilised heart failure
Heart, September 1, 2007; 93(9): 1093 - 1097.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D. Vollmann, H. Nagele, P. Schauerte, U. Wiegand, C. Butter, G. Zanotto, A. Quesada, A. Guthmann, M. R.S. Hill, B. Lamp, et al.
Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure
Eur. Heart J., August 1, 2007; 28(15): 1835 - 1840.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. L. Miller, K. A. Hartman, M. F. Burritt, D. E. Grill, R. J. Rodeheffer, J. C. Burnett Jr, and A. S. Jaffe
Serial Biomarker Measurements in Ambulatory Patients With Chronic Heart Failure: The Importance of Change Over Time
Circulation, July 17, 2007; 116(3): 249 - 257.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Komajda, O. Hanon, M. Hochadel, F. Follath, K. Swedberg, A. Gitt, and J. G.F. Cleland
Management of octogenarians hospitalized for heart failure in Euro Heart Failure Survey I
Eur. Heart J., June 1, 2007; 28(11): 1310 - 1318.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Jourdain, G. Jondeau, F. Funck, P. Gueffet, A. Le Helloco, E. Donal, J. F. Aupetit, M. C. Aumont, M. Galinier, J. C. Eicher, et al.
Plasma Brain Natriuretic Peptide-Guided Therapy to Improve Outcome in Heart Failure: The STARS-BNP Multicenter Study
J. Am. Coll. Cardiol., April 24, 2007; 49(16): 1733 - 1739.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. A. Konstam, M. Gheorghiade, J. C. Burnett Jr, L. Grinfeld, A. P. Maggioni, K. Swedberg, J. E. Udelson, F. Zannad, T. Cook, J. Ouyang, et al.
Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure: The EVEREST Outcome Trial
JAMA, March 28, 2007; 297(12): 1319 - 1331.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. Gheorghiade, M. A. Konstam, J. C. Burnett Jr, L. Grinfeld, A. P. Maggioni, K. Swedberg, J. E. Udelson, F. Zannad, T. Cook, J. Ouyang, et al.
Short-term Clinical Effects of Tolvaptan, an Oral Vasopressin Antagonist, in Patients Hospitalized for Heart Failure: The EVEREST Clinical Status Trials
JAMA, March 28, 2007; 297(12): 1332 - 1343.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
U. Elkayam, P. Hatamizadeh, and M. Janmohamed
The Challenge of Correcting Volume Overload in Hospitalized Patients With Decompensated Heart Failure
J. Am. Coll. Cardiol., February 13, 2007; 49(6): 684 - 686.
[Full Text] [PDF]


Home page
Eur Heart JHome page
M. Schaufelberger and A. Rosengren
Heart failure in different occupational classes in Sweden
Eur. Heart J., January 2, 2007; 28(2): 212 - 218.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
K. Siirila-Waris, J. Lassus, J. Melin, K. Peuhkurinen, M. S. Nieminen, V.-P. Harjola, and for the FINN-AKVA study group
Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure
Eur. Heart J., December 2, 2006; 27(24): 3011 - 3017.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. S. Nieminen, D. Brutsaert, K. Dickstein, H. Drexler, F. Follath, V.-P. Harjola, M. Hochadel, M. Komajda, J. Lassus, J. L. Lopez-Sendon, et al.
EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population
Eur. Heart J., November 2, 2006; 27(22): 2725 - 2736.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
L. W. Eurlings, J. L. Januzzi, and Y. M. Pinto
Is acute heart failure a highly prevalent orphan disease?
Eur. Heart J., November 2, 2006; 27(22): 2619 - 2620.
[Full Text] [PDF]


Home page
Eur Heart J SupplHome page
M. S. Nieminen
Key issues of European Society of Cardiology guidelines on acute heart failure
Eur. Heart J. Suppl., September 1, 2006; 8(suppl_E): E6 - E11.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
L. Tavazzi, A. P. Maggioni, D. Lucci, G. Cacciatore, G. Ansalone, F. Oliva, M. Porcu, and on behalf of the Italian survey on Acute Heart Fai
Nationwide survey on acute heart failure in cardiology ward services in Italy
Eur. Heart J., May 2, 2006; 27(10): 1207 - 1215.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. R. Cowie, M. Komajda, T. Murray-Thomas, J. Underwood, B. Ticho, and on behalf of the POSH Investigators
Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH)
Eur. Heart J., May 2, 2006; 27(10): 1216 - 1222.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
L Purek, K Laule-Kilian, A Christ, T Klima, M E Pfisterer, A P Perruchoud, and C Mueller
Coronary artery disease and outcome in acute congestive heart failure
Heart, May 1, 2006; 92(5): 598 - 602.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
P A Mehta and M R Cowie
Gender and heart failure: a population perspective
Heart, May 1, 2006; 92(suppl_3): iii14 - iii18.
[Full Text] [PDF]


Home page
CirculationHome page
A. K. Chung, S. R. Das, D. Leonard, R. M. Peshock, F. Kazi, S. M. Abdullah, R. M. Canham, B. D. Levine, and M. H. Drazner
Women Have Higher Left Ventricular Ejection Fractions Than Men Independent of Differences in Left Ventricular Volume: The Dallas Heart Study
Circulation, March 28, 2006; 113(12): 1597 - 1604.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
F. A. McAlister, J. V. Tu, A. Newman, D. S. Lee, S. Kimber, B. Cujec, and P. W. Armstrong
How many patients with heart failure are eligible for cardiac resynchronization? Insights from two prospective cohorts
Eur. Heart J., February 1, 2006; 27(3): 323 - 329.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Anwaruddin, D. M. Lloyd-Jones, A. Baggish, A. Chen, D. Krauser, R. Tung, C. Chae, and J. L. Januzzi Jr
Renal Function, Congestive Heart Failure, and Amino-Terminal Pro-Brain Natriuretic Peptide Measurement: Results From the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study
J. Am. Coll. Cardiol., January 3, 2006; 47(1): 91 - 97.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. C. Daubert, C. Leclercq, and P. Mabo
There Is Plenty of Room for Cardiac Resynchronization Therapy Devices Without Back-Up Defibrillators in the Electrical Treatment of Heart Failure
J. Am. Coll. Cardiol., December 20, 2005; 46(12): 2204 - 2207.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Gheorghiade, F. Zannad, G. Sopko, L. Klein, I. L. Pina, M. A. Konstam, B. M. Massie, E. Roland, S. Targum, S. P. Collins, et al.
Acute Heart Failure Syndromes: Current State and Framework for Future Research
Circulation, December 20, 2005; 112(25): 3958 - 3968.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Anwaruddin, D. M. Lloyd-Jones, A. Baggish, A. Chen, D. Krauser, R. Tung, C. Chae, and J. L. Januzzi Jr
Renal Function, Congestive Heart Failure, and Amino-Terminal Pro-Brain Natriuretic Peptide Measurement: Results From the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study
J. Am. Coll. Cardiol., December 13, 2005; (2005) j.jacc.2005.08.051v1.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. J. Lenzen, E. Boersma, W. J.M. Scholte op Reimer, A. H.M.M. Balk, M. Komajda, K. Swedberg, F. Follath, M. Jimenez-Navarro, M. L. Simoons, and J. G.F. Cleland
Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure
Eur. Heart J., December 2, 2005; 26(24): 2706 - 2713.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
I. Squire
Managing patients with heart failure: the reality of clinical practice
Eur. Heart J., December 2, 2005; 26(24): 2611 - 2613.
[Full Text] [PDF]


Home page
HeartHome page
J D Newton, H M Blackledge, and I B Squire
Ethnicity and variation in prognosis for patients newly hospitalised for heart failure: a matched historical cohort study
Heart, December 1, 2005; 91(12): 1545 - 1550.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
K. K.A. Witte, N. P. Nikitin, A. C. Parker, S. von Haehling, H.-D. Volk, S. D. Anker, A. L. Clark, and J. G.F. Cleland
The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure
Eur. Heart J., November 1, 2005; 26(21): 2238 - 2244.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
M. Tendera
Epidemiology, treatment, and guidelines for the treatment of heart failure in Europe
Eur. Heart J. Suppl., October 1, 2005; 7(suppl_J): J5 - J9.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
J. J.V. McMurray
The role of angiotensin II receptor blockers in the management of heart failure
Eur. Heart J. Suppl., October 1, 2005; 7(suppl_J): J10 - J14.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
A. P. Maggioni
Review of the new ESC guidelines for the pharmacological management of chronic heart failure
Eur. Heart J. Suppl., October 1, 2005; 7(suppl_J): J15 - J20.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
K. Swedberg and I. Ekman
Integrating heart failure guidelines into clinical practice
Eur. Heart J. Suppl., October 1, 2005; 7(suppl_J): J21 - J25.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Yoshida, K. Yamamoto, T. Mano, Y. Sakata, M. Nishio, T. Ohtani, M. Hori, T. Miwa, and T. Masuyama
Different effects of long- and short-acting loop diuretics on survival rate in Dahl high-salt heart failure model rats
Cardiovasc Res, October 1, 2005; 68(1): 118 - 127.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
R. de Silva, N. P. Nikitin, S. Bhandari, A. Nicholson, A. L. Clark, and J. G.F. Cleland
Atherosclerotic renovascular disease in chronic heart failure: should we intervene?
Eur. Heart J., August 2, 2005; 26(16): 1596 - 1605.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
K. Swedberg, L. G. Olsson, A. Charlesworth, J. Cleland, P. Hanrath, M. Komajda, M. Metra, C. Torp-Pedersen, and P. Poole-Wilson
Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET
Eur. Heart J., July 1, 2005; 26(13): 1303 - 1308.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members, K. Swedberg, Writing Committee:, J. Cleland, H. Dargie, H. Drexler, F. Follath, M. Komajda, L. Tavazzi, O. A. Smiseth, et al.
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology
Eur. Heart J., June 1, 2005; 26(11): 1115 - 1140.
[Full Text] [PDF]


Home page
Eur Heart JHome page
C. A. Daly, F. Clemens, J. L. L. Sendon, L. Tavazzi, E. Boersma, N. Danchin, F. Delahaye, A. Gitt, D. Julian, D. Mulcahy, et al.
The clinical characteristics and investigations planned in patients with stable angina presenting to cardiologists in Europe: from the Euro Heart Survey of Stable Angina
Eur. Heart J., May 2, 2005; 26(10): 996 - 1010.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
M. Gheorghiade and F. Zannad
Modern management of acute heart failure syndromes
Eur. Heart J. Suppl., April 1, 2005; 7(suppl_B): B3 - B7.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
F. Zannad
Acute heart failure syndromes: the 'Cinderella' of heart failure research
Eur. Heart J. Suppl., April 1, 2005; 7(suppl_B): B8 - B12.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
M. Gheorghiade and G. Filippatos
Reassessing treatment of acute heart failure syndromes: the ADHERE Registry
Eur. Heart J. Suppl., April 1, 2005; 7(suppl_B): B13 - B19.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Endorsed by the European Society of Intensive Care, Authors/Task Force Members, M. S. Nieminen, M. Bohm, M. R. Cowie, H. Drexler, G. S. Filippatos, G. Jondeau, Y. Hasin, J. Lopez-Sendon, et al.
Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology
Eur. Heart J., February 2, 2005; 26(4): 384 - 416.
[Full Text] [PDF]


Home page
Eur Heart JHome page
F. Gustafsson and J. M. O. Arnold
COACHes, players, and heart failure teams: reply
Eur. Heart J., February 1, 2005; 26(3): 314 - 315.
[Full Text] [PDF]


Home page
Eur Heart JHome page
F. Gustafsson, C. Torp-Pedersen, M. Seibaek, H. Burchardt, L. Kober, and for the DIAMOND study group
Effect of age on short and long-term mortality in patients admitted to hospital with congestive heart failure
Eur. Heart J., October 1, 2004; 25(19): 1711 - 1717.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
A. Bundkirchen and R. H.G Schwinger
Epidemiology and economic burden of chronic heart failure
Eur. Heart J. Suppl., August 1, 2004; 6(suppl_D): D57 - D60.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
K. Dickstein
Appearances can deceive: even brave hearts can fail
Eur. Heart J., July 2, 2004; 25(14): 1181 - 1182.
[Full Text] [PDF]


Home page
Eur Heart JHome page
M.J Lenzen, W.J.M Scholte op Reimer, E Boersma, P.J.M.J Vantrimpont, F Follath, K Swedberg, J Cleland, and M Komajda
Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey
Eur. Heart J., July 2, 2004; 25(14): 1214 - 1220.
[Abstract] [Full Text] [PDF]